Published in J Med Microbiol on February 01, 2005
New advances in the treatment of Clostridium difficile infection (CDI). Ther Clin Risk Manag (2008) 0.98
The host immune response to Clostridium difficile infection. Ther Adv Infect Dis (2013) 0.96
Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis. Autoimmune Dis (2015) 0.89
Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection. Infect Immun (2011) 0.89
Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives. Toxins (Basel) (2010) 0.88
Antibodies for treatment of Clostridium difficile infection. Clin Vaccine Immunol (2014) 0.87
Immune-based treatment and prevention of Clostridium difficile infection. Hum Vaccin Immunother (2014) 0.84
Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. World J Gastroenterol (2015) 0.83
Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut (2007) 0.81
An update on antibody-based immunotherapies for Clostridium difficile infection. Clin Exp Gastroenterol (2016) 0.80
Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies. Infect Immun (2015) 0.80
Bovine antibody-based oral immunotherapy for reduction of intragastric Helicobacter pylori colonization: a randomized clinical trial. Can J Gastroenterol (2011) 0.78
Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review. Geriatr Orthop Surg Rehabil (2012) 0.76
Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response. Vaccine (2013) 0.76
The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial. J Transl Med (2015) 0.75
Equine hyperimmune serum protects mice against Clostridium difficile spore challenge. J Vet Sci (2013) 0.75
Treatment of Recurrent Clostridium difficile Diarrhea. Gastroenterol Hepatol (N Y) (2006) 0.75
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
Clostridium difficile infection in Europe: a hospital-based survey. Lancet (2011) 6.25
High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol (2010) 5.71
Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int (2005) 5.49
Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis (2011) 3.93
Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis (2008) 3.49
Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis (2007) 2.90
Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis (2011) 2.84
Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis (2007) 2.73
Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Med Microbiol (2007) 2.18
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis (2013) 2.09
An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis (2007) 1.94
Azole-resistant central nervous system aspergillosis. Clin Infect Dis (2009) 1.94
Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother (2008) 1.91
Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol (2006) 1.87
Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol (2005) 1.80
Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol (2005) 1.78
Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol (2004) 1.73
Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol (2009) 1.65
Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis (2006) 1.49
Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother (2011) 1.49
Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Clin Infect Dis (2008) 1.48
Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One (2012) 1.40
Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother (2011) 1.39
Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care (2010) 1.38
Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes. J Clin Microbiol (2003) 1.37
All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis (2013) 1.26
Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum. Clin Infect Dis (2005) 1.21
Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg (2006) 1.13
Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect Genet Evol (2012) 1.12
Typing Clostridium difficile strains based on tandem repeat sequences. BMC Microbiol (2009) 1.06
Clostridium difficile: controversies and approaches to management. Curr Opin Infect Dis (2009) 1.04
Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection? Clin Infect Dis (2008) 1.03
TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm. PLoS One (2012) 1.02
Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters. J Neurosurg (2005) 1.02
Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis (2010) 1.00
Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients. Support Care Cancer (2012) 0.98
C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PLoS One (2012) 0.98
Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. J Med Microbiol (2006) 0.98
Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology (2011) 0.97
Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother (2010) 0.97
High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS One (2012) 0.96
Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet (2011) 0.94
Detection of respiratory pathogens by real-time PCR in children with clinical suspicion of pertussis. Eur J Pediatr (2006) 0.93
Prevalence of Clostridium difficile in retailed meat in the Netherlands. Int J Food Microbiol (2010) 0.93
An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora. Chemotherapy (2003) 0.93
The sonographic characteristics of nontuberculous mycobacterial cervicofacial lymphadenitis in children. Pediatr Radiol (2006) 0.93
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications. J Antimicrob Chemother (2013) 0.92
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days). BMC Infect Dis (2009) 0.92
First report of Atopobium vaginae bacteremia with fetal loss after chorionic villus sampling. J Clin Microbiol (2011) 0.91
Novel risk factors for Clostridium difficile-associated disease in a setting of endemicity? Clin Infect Dis (2008) 0.90
Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population. J Clin Microbiol (2012) 0.89
Array comparative hybridisation reveals a high degree of similarity between UK and European clinical isolates of hypervirulent Clostridium difficile. BMC Genomics (2010) 0.88
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. Clin Infect Dis (2012) 0.87
[Changing epidemiology of infections in the Netherlands in 2008/'09]. Ned Tijdschr Geneeskd (2010) 0.86
The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile. Regul Toxicol Pharmacol (2007) 0.83
Clostridium difficile infection caused by binary toxin-positive strains. Emerg Infect Dis (2013) 0.83
Vibrio cholerae non-O1 bacteraemia: description of three cases in the Netherlands and a literature review. Euro Surveill (2016) 0.82
A novel secreted metalloprotease (CD2830) from Clostridium difficile cleaves specific proline sequences in LPXTG cell surface proteins. Mol Cell Proteomics (2014) 0.82
Clostridium difficile TcdC protein binds four-stranded G-quadruplex structures. Nucleic Acids Res (2013) 0.82
Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Euro Surveill (2015) 0.82
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach. J Antimicrob Chemother (2007) 0.81
Clostridium difficile infection associated with pig farms. Emerg Infect Dis (2013) 0.81
Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut (2007) 0.81
Analysis of a Clostridium difficile PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn6164. BMC Microbiol (2012) 0.81
Interpretation and precision of the Observer Scar Assessment Scale improved by a revised scoring. J Clin Epidemiol (2008) 0.81
Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J Clin Microbiol (2004) 0.79
Is the Lower Gastrointestinal Route Really Preferred Over the Upper Gastrointestinal Route for Fecal Microbiota Transfer? J Clin Gastroenterol (2016) 0.78
Rapidly growing mycobacteria: emerging pathogens in cosmetic procedures of the skin. Clin Infect Dis (2009) 0.78
Serum- and animal tissue-free medium for transport and growth of Helicobacter pylori. FEMS Immunol Med Microbiol (2007) 0.77
Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013. Euro Surveill (2016) 0.77
Drug susceptibility testing of nontuberculous mycobacteria. Future Microbiol (2014) 0.77
Capillary-electrophoresis mass spectrometry for the detection of carbapenemases in (multi-)drug-resistant Gram-negative bacteria. Anal Chem (2014) 0.77
Pelvic actinomycosis-like disease due to Propionibacterium propionicum after hysteroscopic removal of an intrauterine device. J Clin Microbiol (2010) 0.77
Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile. J Antimicrob Chemother (2010) 0.76
Induction of Staphylococcus aureus-specific IgA and agglutination potency in milk of cows by mucosal immunization. Vaccine (2009) 0.76
Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Pediatr Infect Dis J (2009) 0.76
First case of an oculofacial lesion due to Mycobacterium haemophilum infection in an immunocompetent child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.75
Selective decontamination of the digestive tract: all questions answered? Crit Care (2003) 0.75
Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Euro Surveill (2016) 0.75
Diagnosis of Clostridium difficile infection using real-time PCR. Methods Mol Biol (2013) 0.75
Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014. Euro Surveill (2016) 0.75
[New treatment options for infections with Clostridium difficile]. Ned Tijdschr Geneeskd (2013) 0.75
Assessment of a school-based mass treatment for soil-transmitted helminth infections in Capiz, the Philippines. Southeast Asian J Trop Med Public Health (2012) 0.75
Survey of Clostridium difficile infection surveillance systems in Europe, 2011. Euro Surveill (2016) 0.75
[Invasive pulmonary aspergillosis in influenza]. Ned Tijdschr Geneeskd (2015) 0.75